Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 158

1.

Prognostic effect of circulating adiponectin in a randomized 2 x 2 trial of low-dose tamoxifen and fenretinide in premenopausal women at risk for breast cancer.

Macis D, Gandini S, Guerrieri-Gonzaga A, Johansson H, Magni P, Ruscica M, Lazzeroni M, Serrano D, Cazzaniga M, Mora S, Feroce I, Pizzamiglio M, Sandri MT, Gulisano M, Bonanni B, Decensi A.

J Clin Oncol. 2012 Jan 10;30(2):151-7. doi: 10.1200/JCO.2011.35.2237. Epub 2011 Dec 12.

2.

Randomized double-blind 2 x 2 trial of low-dose tamoxifen and fenretinide for breast cancer prevention in high-risk premenopausal women.

Decensi A, Robertson C, Guerrieri-Gonzaga A, Serrano D, Cazzaniga M, Mora S, Gulisano M, Johansson H, Galimberti V, Cassano E, Moroni SM, Formelli F, Lien EA, Pelosi G, Johnson KA, Bonanni B.

J Clin Oncol. 2009 Aug 10;27(23):3749-56. doi: 10.1200/JCO.2008.19.3797. Epub 2009 Jul 13.

3.

Effect of fenretinide and low-dose tamoxifen on insulin sensitivity in premenopausal women at high risk for breast cancer.

Johansson H, Gandini S, Guerrieri-Gonzaga A, Iodice S, Ruscica M, Bonanni B, Gulisano M, Magni P, Formelli F, Decensi A.

Cancer Res. 2008 Nov 15;68(22):9512-8. doi: 10.1158/0008-5472.CAN-08-0553.

4.

Circulating hormones and breast cancer risk in premenopausal women: a randomized trial of low-dose tamoxifen and fenretinide.

Johansson H, Bonanni B, Gandini S, Guerrieri-Gonzaga A, Cazzaniga M, Serrano D, Macis D, Puccio A, Sandri MT, Gulisano M, Formelli F, Decensi A.

Breast Cancer Res Treat. 2013 Dec;142(3):569-78. doi: 10.1007/s10549-013-2768-7. Epub 2013 Nov 17.

PMID:
24241787
5.

Preliminary results on safety and activity of a randomized, double-blind, 2 x 2 trial of low-dose tamoxifen and fenretinide for breast cancer prevention in premenopausal women.

Guerrieri-Gonzaga A, Robertson C, Bonanni B, Serrano D, Cazzaniga M, Mora S, Gulisano M, Johansson H, Formelli F, Intra M, Latronico A, Franchi D, Pelosi G, Johnson K, Decensi A.

J Clin Oncol. 2006 Jan 1;24(1):129-35. Erratum in: J Clin Oncol. 2006 Jul 1;24(19):3221. Formelli, Franca [added].

PMID:
16382122
6.

Relationships between plasma insulin-like growth factor-I and insulin-like growth factor binding protein-3 and second breast cancer risk in a prevention trial of fenretinide.

Decensi A, Veronesi U, Miceli R, Johansson H, Mariani L, Camerini T, Di Mauro MG, Cavadini E, De Palo G, Costa A, Perloff M, Malone WF, Formelli F.

Clin Cancer Res. 2003 Oct 15;9(13):4722-9.

7.

Adiponectin: a risk biomarker and attractive target for chemoprevention.

Fabian CJ.

J Clin Oncol. 2012 Jan 10;30(2):124-6. doi: 10.1200/JCO.2011.38.5500. Epub 2011 Dec 12. No abstract available.

PMID:
22162567
8.

The relation of leptin and adiponectin with breast density among premenopausal women.

Maskarinec G, Woolcott C, Steude JS, Franke AA, Cooney RV.

Eur J Cancer Prev. 2010 Jan;19(1):55-60. doi: 10.1097/CEJ.0b013e328333fb0e.

9.

Plasma adiponectin and insulin sensitivity in overweight and normal-weight middle-aged premenopausal women.

Jürimäe J, Jürimäe T, Ring-Dimitriou S, LeMura LM, Arciero PJ, von Duvillard SP.

Metabolism. 2009 May;58(5):638-43. doi: 10.1016/j.metabol.2008.12.009.

PMID:
19375586
10.

Fifteen-year results of a randomized phase III trial of fenretinide to prevent second breast cancer.

Veronesi U, Mariani L, Decensi A, Formelli F, Camerini T, Miceli R, Di Mauro MG, Costa A, Marubini E, Sporn MB, De Palo G.

Ann Oncol. 2006 Jul;17(7):1065-71. Epub 2006 May 4.

PMID:
16675486
11.

25-Hydroxy vitamin-D, obesity, and associated variables as predictors of breast cancer risk and tamoxifen benefit in NSABP-P1.

Amir E, Cecchini RS, Ganz PA, Costantino JP, Beddows S, Hood N, Goodwin PJ.

Breast Cancer Res Treat. 2012 Jun;133(3):1077-88. doi: 10.1007/s10549-012-2012-x. Epub 2012 Mar 14. Erratum in: Breast Cancer Res Treat. 2012 Oct;135(3):923.

12.

Chemoprevention of breast cancer: the Italian experience.

Decensi A, Bonanni B, Guerrieri-Gonzaga A, Torrisi R, Manetti L, Robertson C, De Palo G, Formelli F, Costa A, Veronesi U.

J Cell Biochem Suppl. 2000;34:84-96. Review.

PMID:
10762020
13.

Insulin- and obesity-related variables in early-stage breast cancer: correlations and time course of prognostic associations.

Goodwin PJ, Ennis M, Pritchard KI, Trudeau ME, Koo J, Taylor SK, Hood N.

J Clin Oncol. 2012 Jan 10;30(2):164-71. doi: 10.1200/JCO.2011.36.2723. Epub 2011 Dec 12.

PMID:
22162568
14.

Randomized trial of fenretinide to prevent second breast malignancy in women with early breast cancer.

Veronesi U, De Palo G, Marubini E, Costa A, Formelli F, Mariani L, Decensi A, Camerini T, Del Turco MR, Di Mauro MG, Muraca MG, Del Vecchio M, Pinto C, D'Aiuto G, Boni C, Campa T, Magni A, Miceli R, Perloff M, Malone WF, Sporn MB.

J Natl Cancer Inst. 1999 Nov 3;91(21):1847-56.

PMID:
10547391
15.

Selective estrogen receptor modulators (SERMs) and retinoids in breast cancer chemoprevention.

Zujewski J.

Environ Mol Mutagen. 2002;39(2-3):264-70. Review.

PMID:
11921197
16.

[Breakthrough in breast cancer chemoprevention].

Kahán Z, Thurzó L.

Orv Hetil. 2003 Mar 30;144(13):597-603. Review. Hungarian.

PMID:
12728784
17.

Fenretinide breast cancer prevention trial: drug and retinol plasma levels in relation to age and disease outcome.

Formelli F, Camerini T, Cavadini E, Appierto V, Villani MG, Costa A, De Palo G, Di Mauro MG, Veronesi U.

Cancer Epidemiol Biomarkers Prev. 2003 Jan;12(1):34-41.

18.

Long-term effectiveness of adjuvant goserelin in premenopausal women with early breast cancer.

Hackshaw A, Baum M, Fornander T, Nordenskjold B, Nicolucci A, Monson K, Forsyth S, Reczko K, Johansson U, Fohlin H, Valentini M, Sainsbury R.

J Natl Cancer Inst. 2009 Mar 4;101(5):341-9. doi: 10.1093/jnci/djn498. Epub 2009 Feb 24.

19.

Insulin-like growth factor I (IGF-I), IGF-binding proteins, and breast cancer.

Krajcik RA, Borofsky ND, Massardo S, Orentreich N.

Cancer Epidemiol Biomarkers Prev. 2002 Dec;11(12):1566-73.

20.

Relationship of plasma leptin and adiponectin concentrations with menopausal status in Tunisian women.

Ben Ali S, Jemaa R, Ftouhi B, Kallel A, Feki M, Slimene H, Kaabachi N.

Cytokine. 2011 Nov;56(2):338-42. doi: 10.1016/j.cyto.2011.06.026. Epub 2011 Jul 28.

PMID:
21802312

Supplemental Content

Support Center